Han Shen

Cancer Institute NSW Fellow, DMG/DIPG Researcher @ Westmead Institute for Medical Research

[Han Shen @hannsshen]

🎉 Our review article is now published in Cancers!
We discuss how H3K27M-driven epigenetic reprogramming shapes metabolism in DMG, the emerging role of dopamine signalling in mitochondrial homeostasis, and therapeutic opportunities targeting the dopamine–mitochondria axis.

[Dr Kristina Cook @kristinasci]

📝 Paper alert: Targeting #DIPG tumor #metabolism, #mitochondria and #hypoxia to #radiosensitize tumors 🧠 ☢️ https://t.co/GWqkULu1zm @hannsshen @Eric73363938 @faiqa_mudassar @DrJeffHolst @GeraldineONei20 @RadOncDoc_Gee

[Han Shen @hannsshen]

@liammendes Many thanks for reporting this, you are a hero now in China!

[Han Shen @hannsshen]

We are hiring a Technical Officer in Radiation Biology group at Centre for Cancer Research, Westmead Institute for Medical Research, please feel free to share! https://t.co/ooHcrhpIJf

[Han Shen @hannsshen]

Westmead Health Precinct researcher receives coveted fellowship to revolutionise treatment for aggressive paediatric brain tumours https://t.co/e8vdRa6QZs

[Han Shen @hannsshen]

@MattDun17 @RUNDIPG Fantastic well done Matt!

[Han Shen @hannsshen]

@ProfDavidZieg @maria_tsoli Congrats @maria_tsoli

[Cancer Institute NSW @cancerNSW]

This #BrainCancerAwarenessMonth, learn about what drives Dr Han Shen, Dr Holly Holliday and Dr Guoying Wang, cancer research fellows working to improve brain cancer outcomes in NSW. Learn more: https://t.co/tvcXvPAxNC

[7NEWS Sydney @7NewsSydney]

Cancer researchers are pleading for extra funding from government to allow more clinical trials to be conducted here in Australia. They're often forced to say no to offers from overseas with patients and their families paying the price. https://t.co/VcAUAEn7HJ #7NEWS

[Han Shen @hannsshen]

Had great two days at #cbcc2023 and presented our work to tackle #DIPG #DMG with our talented PhD student @faiqa_mudassar Great to meet with old friends and new collaborators for improving our future work. Thanks support from @_RCDFoundation @braincancer_AU @CureStartsNowAU

[Cure Brain Cancer @braincancer_AU]

We are excited to announce the launch of our 2023 Early Career Fellowship which will offer grants-in-aid of up to $345,000 over three years. Applications will open on the 14th of March 2023.
For more information: https://t.co/kzlOnAwGCA
#CureBrainCancer #BrainCancerResearch

[Han Shen @hannsshen]

I am honoured to receive the Career Development Fellowship from @cancerNSW. We will be studying novel radiosensitising therapies to improve the survival of children diagnosed with diffuse midline gliomas. Also thanks to @Eric73363938 @WestmeadInst @Sydney_Uni @GeraldineONei20

[Cancer Institute NSW @cancerNSW]

We are excited to announce support for 15 new cancer research fellowships and a new translational research program in NSW. Find out about the grants: https://t.co/KblzF7Y6OA #cancerresearch

[Han Shen @hannsshen]

We are hiring a postdoctoral scientist to join our Translational Radiation Biology and Oncology Group located in Westmead Institute Medical Research. Please feel free to share this info with anyone who is interested in applying for this position. https://t.co/75QyRV1RT3

[Centre for Drug Discovery Innovation @Sydney_DDI]

Applications are now open for the 2022 DDI ECR Awards!

If you're a HDR or ECR who's achieved something notable this year in drug discovery-related research, nominate yourself here by Nov. 2: https://t.co/aUp2oclmlX #DrugDiscovery

[Han Shen @hannsshen]

@SevimNalkiran Does that remind you of Australia 😁

[Han Shen @hannsshen]

@ProfDavidZieg @KidsCancerInst @Carolinejatkins Congrats David!

[Han Shen @hannsshen]

Pleased to share our freshly published review focusing on how hypoxia could be a potential barrier to the combined PD-1/PD-L1 blockade and radiotherapy. ⁦@Eric73363938⁩ ⁦@kristinasci⁩ https://t.co/S7Gbhpd6TJ

[Han Shen @hannsshen]

I’m very excited to be part of DDI ECR committee and looking forward to working with this great team and contributing to drug discovery research.

[Centre for Drug Discovery Innovation @Sydney_DDI]

We'd like to introduce two new members of the DDI ECR Committee: Dr @AsterPijning and Dr @hannsshen.

They'll be working to support and provide opportunities for the DDI's HDR + ECR cohort - like at next month's ECR Symposium (https://t.co/1ukz8PdFof)

Welcome, Aster and Han!

[Han Shen @hannsshen]

@KimHanssen1 @KidsCancerInst @UNSWMedicine Congrats!

[Han Shen @hannsshen]

@NSWHealth @Dom_Perrottet said "We are currently tracking at both an ICU and hospitalisation rate here in NSW better than the best case scenario we released last week. So that is encouraging, reassuring and pleasing." Is it appropriate to say Better, Encouraging, Reassuring and Pleasing?